Royalty Pharma plc (RPRX) Reports Q4 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $61.73 +3.42%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
JAGX, CLIR, ZTO, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
JAGX, CLIR, ZTO, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- UBS Upgrades Stockland (SGP:AU) (STKAF) to Buy
- JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
